RxDoctor Payments DataLook up a doctor →

Robert Parrott, DO

Family Medicine · Hot Springs, ARNPI 1508827700

Payments from drug & device makers

$14,936in general payments, 2019–2025

Across 1,011 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Amgen$2K
  • AbbVie$1K
  • Pfizer$1K
  • GSK$1K
  • Lilly USA, LLC$1K
  • plus $7K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca108$1,791
Amgen(2 entities)122$1,765
AbbVie(2 entities)112$1,386
Pfizer103$1,298
GSK78$1,030
Lilly USA, LLC83$1,002
Novo Nordisk54$761
Antares Pharma, Inc.27$553
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC27$411
Exact Sciences22$363
Boehringer Ingelheim23$348
Takeda Pharmaceuticals U.S.A., Inc.18$328
Dexcom, Inc.20$323
Amarin Pharma, Inc.18$309
Novartis21$291
Johnson & Johnson14$244
Kowa Pharmaceuticals America, Inc.18$232
Axsome Therapeutics, Inc.8$211
Astellas Pharma US Inc8$185
Abbott10$183
Nestle Healthcare Nutrition Inc.7$150
Biohaven Pharmaceutical Holding Company Ltd.7$148
Biohaven Pharmaceuticals, Inc.8$141
Esperion Therapeutics, Inc.7$112
Radius Health, Inc.7$103
Halozyme Inc5$87
Eisai Inc.6$83
Lundbeck LLC5$75
Teva Pharmaceuticals USA, Inc.5$71
Sanofi-aventis U.S. LLC5$67
Shield Therapeutics Inc4$64
Merck5$63
Mylan Specialty L.p.4$63
Almatica Pharma LLC3$59
Genentech USA, Inc.4$52
Regeneron Healthcare Solutions, Inc.3$51
Impel Pharmaceuticals Inc.3$49
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$39
Gilead2$37
Seqirus USA Inc2$37
Medline Industries LP1$37
Supernus Pharmaceuticals, Inc.2$35
Idorsia Pharmaceuticals US Inc2$26
Sunovion Pharmaceuticals Inc.2$24
Ironwood Pharmaceuticals, Inc2$24
Biomerieux Inc1$20
Bardy Diagnostics, Inc.1$20
Neuronetics, Inc.1$18
Sanofi Pasteur Inc.1$18
Redhill Biopharma Inc.1$17
Adlon Therapeutics L.p.1$16
Phathom Pharmaceuticals, Inc.1$16
Shire North American Group Inc1$16
Sumitomo Pharma America, Inc.1$16
Nevro Corp.1$16
Acella Pharmaceuticals, LLC1$13
E.r. Squibb & Sons, L.L.C.1$13
Otsuka America Pharmaceutical, Inc.1$13
Arbor Pharmaceuticals, Inc.1$13

How this compares

$14,936 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas →

Medicare billing

Part B allowed, 2024
$397,966
Medicare patients
567
Services billed
16,528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Hot Springs

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →